DNage B.V.

DR Molenwaterplein 50, Room: Ee 702
3015 GE Rotterdam
Netherlands

Contact

About DNage

DNage is a life sciences company founded in 2004 as a spin off from the Department of Genetics of the Erasmus Medical Center Rotterdam. The Company was seed-funded through an equity investment of an international syndicate of venture capitalists including LSP (NL) and Inventages (CH).

Product portfolio of DNage

Product portfolio

Show all

News about DNage

21-Jul-2010 | business & finance

Pharming completes spin-off of DNage

Biotech company Pharming Group NV announced that, following the settlement agreement of May 2010 with the former DNage shareholders, which agreement ...

Read news

16-Jul-2008 | science

Dnage to Participate in European Study on Biomarkers of Ageing

Biotech company Pharming Group NV announced that its wholly owned subsidiary DNage is participating in a large European study, called MARK-AGE, to identify ...

Read news

29-Jan-2008 | science

Pharming receives funding for development of new treatments for premature ageing diseases

Pharming Group NV announced that its wholly owned subsidiary DNage will head a collaborative Research and Development effort to identify novel biomarkers ...

Read news

02-May-2006 | science

DNage, Loders Croklaan, BG Medicine and Erasmus announce collaboration in the field of type II diabetes

DNage BV, Loders Croklaan BV, through its wholly owned subsidiary Lipid Nutrition BV ("Lipid Nutrition"), BG Medicine Inc ("BG Medicine") and the Erasmus ...

Read news

Show more news about DNage

Get the life science industry in your inbox

DNage B.V.

About DNage

Product portfolio of DNage

Product portfolio

News about DNage

Pharming completes spin-off of DNage

Dnage to Participate in European Study on Biomarkers of Ageing

Pharming receives funding for development of new treatments for premature ageing diseases

DNage, Loders Croklaan, BG Medicine and Erasmus announce collaboration in the field of type II diabetes

Here you will find DNage B.V.

DNage B.V.